Given Imaging to Present at Upcoming Investor Conferences
September 07 2011 - 7:00AM
Marketwired
Given Imaging (NASDAQ: GIVN) today announced that management will
present at the following investor conferences in September:
- Rodman & Renshaw 13th Annual Healthcare Conference in New
York on September 13, 2011. Yuval Yanai, CFO, will present at 10:30
am ET.
- Morgan Stanley Global Healthcare Unplugged Conference in New
York on September 13, 2011. Homi Shamir, President and CEO, will
present at 1:35 pm ET.
- UBS Global Life Sciences Conference in New York on September
20, 2011. Homi Shamir will present at 11:00 am ET.
- Jefferies 2011 Global Life Sciences Conference in London on
September 27, 2011. Gilad Mamlok, VP Finance, will present at 8:00
am local time.
- JMP Securities Healthcare Conference in New York on September
27, 2011. Homi Shamir will present at 10:30 am ET.
To access live webcasts of these presentations, visit
www.givenimaging.com and click 'About Given Imaging.' The webcasts
will be available in the Investor Relations section.
About Given Imaging Ltd. Since pioneering
the field of capsule endoscopy in 2001, Given Imaging has become a
world leader in GI medical devices, offering health care providers
a range of innovative options for visualizing, diagnosing and
monitoring the digestive system. The company offers a broad product
portfolio including PillCam® video capsules for the small bowel,
esophagus and colon [PillCam® COLON not approved for use in the
United States.], industry-leading ManoScan™ high-resolution
manometry and Bravo® wireless and Digitrapper® pH and impedance
products. Given Imaging is committed to delivering breakthrough
innovations to the GI community and supporting its ongoing clinical
needs. Given Imaging's headquarters are located in Yoqneam, Israel,
with operating subsidiaries in the United States, Germany, France,
Japan, Australia, Vietnam and Hong Kong. For more information,
please visit www.givenimaging.com.
Forward-Looking Statements This press
release contains forward-looking statements within the meaning of
the "safe harbor" provisions of the U.S. Private Securities
Litigation Reform Act of 1995. These forward-looking statements
include, but are not limited to, projections about our business and
our future revenues, expenses and profitability. Forward-looking
statements may be, but are not necessarily, identified by the use
of forward-looking terminology such as "may," "anticipates,"
"estimates," "expects," "intends," "plans," "believes," and words
and terms of similar substance. Forward-looking statements involve
known and unknown risks, uncertainties and other factors which may
cause the actual events, results, performance, circumstances or
achievements of the Company to be materially different from any
future events, results, performance, circumstances or achievements
expressed or implied by such forward-looking statements. Factors
that could cause actual events, results, performance, circumstances
or achievements to differ from such forward-looking statements
include, but are not limited to, the following: (1) our ability to
develop and bring to market new products, (2) our ability to
successfully complete any necessary or required clinical studies
with our products, (3) our ability to receive regulatory clearance
or approval to market our products or changes in regulatory
environment, (4) our success in implementing our sales, marketing
and manufacturing plans, (5) the level of adoption of our products
by medical practitioners, (6) the emergence of other products that
may make our products obsolete, (7) lack of an appropriate bowel
preparation materials to be used with our PillCam COLON capsule,
(8) protection and validity of patents and other intellectual
property rights, (9) the impact of currency exchange rates, (10)
the effect of competition by other companies, (11) the outcome of
significant litigation, (12) our ability to obtain reimbursement
for our product from government and commercial payors, (13)
quarterly variations in operating results, (14) the possibility of
armed conflict or civil or military unrest in Israel, (15) the
impact of global economic conditions, (16) our ability to
successfully integrate acquired businesses, (17) changes and
reforms in applicable healthcare laws and regulations, (18) adverse
events or product quality issues that could require us to recall
products and impact our sales, and (19) other risks and factors
disclosed in our filings with the U.S. Securities and Exchange
Commission, including, but not limited to, risks and factors
identified under such headings as "Risk Factors," "Cautionary
Language Regarding Forward-Looking Statements" and "Operating
Results and Financial Review and Prospects" in the Company's Annual
Report on Form 20-F for the year ended December 31, 2010. You are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Except for the Company's ongoing obligations to disclose material
information under the applicable securities laws, it undertakes no
obligation to release publicly any revisions to any forward-looking
statements, to report events or to report the occurrence of
unanticipated events.
For further information contact: Fern Lazar/David Carey Lazar
Partners Ltd. 1-212-867-1768 flazar@lazarpartners.com
dcarey@lazarpartners.com
Given Imaging (NASDAQ:GIVN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Given Imaging (NASDAQ:GIVN)
Historical Stock Chart
From Jul 2023 to Jul 2024